Agency · +3 more types
“From sophisticated global economic models to HTA-ready cost-effectiveness analyses, local budget impact models and user-friendly market access tools, our experienced, strategic…”Source: costellomedical.com
Also offers: HTA Strategy & Submissions, Evidence Synthesis & Indirect Comparisons, +2 more
Consulting / Advisory Firm · +4 more types
Products: Lumanity Illuminator, Evidence Illuminator +9 more
“We provide health economic modeling at every stage of the drug development process.”Source: lumanity.com
Also offers: Market Access Strategy & Launch Planning, Brand Strategy & Positioning, +1 more
Consulting / Advisory Firm · +2 more types
“Builds economic models and comparative analyses to demonstrate clinical and economic value.”Source: openhealthgroup.com
Also offers: HTA Strategy & Submissions, RWE for Access & HEOR, +3 more
Agency · +3 more types
Products: AccessGenius, AccessGenius Insights +9 more
“We develop credible evidence-based health economic models to quantify the value and population health impact of your healthcare innovation: cost-effectiveness and budget impact…”Source: precisionaq.com
Also offers: Market Access Strategy & Launch Planning, Key Opinion Leader (KOL) & Stakeholder Engagement, +3 more
Service Provider · +2 more types
Products: D.AI.M.I.
“We build cost-utility analyses, cost-effectiveness analyses, and cost-benefit models tailored to HTA body requirements and payer decision frameworks across multiple markets.”Source: plglifesciences.com
Also offers: Regulatory Development Strategy & Agency Interactions, End-to-End Pharmacovigilance Outsourcing, +6 more
CRO / Research Services Provider · +7 more types
Products: IQVIA Vigilance Platform, SmartSolve +4 more
“Partner with IQVIA to access health economic modeling solutions to support market-specific reimbursement, market access and high-impact scientific publications.”Source: iqvia.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Real-World Data Platform, +6 more
Agency · +3 more types
Products: MedOcean, KAOS +1 more
“We use customized healthcare economic modeling tools that demonstrate value by aligning clinical benefit with relevant cost impact. Our tools allow formulary decision-makers to…”Source: klick.com
Also offers: Creative Campaign Development, Brand Strategy & Positioning, +3 more
Software / Technology Platform · +3 more types
Products: Healthcare Map, Marmot +9 more
“Run cost-effectiveness studies of varying interventions, support post-market surveillance, and boost HEOR studies.”Source: komodohealth.com
Also offers: Real-World Data Platform, Patient Journey & Population Analytics, +1 more
Software / Technology Platform · +4 more types
Products: Axtria SalesIQ, Axtria MarketingIQ +7 more
“Flexible RWD simulations and real-world analytics enabled label expansion, clinical guideline updates, and economic models for payer engagement, strengthening scientific…”Source: axtria.com
Also offers: Commercial Performance Measurement, Territory Alignment & Roster Management, +4 more
Agency · +3 more types
“Our technical experts and trusted partners support economic model development and adaptation, from identifying inputs, developing, adapting, stress-testing and scenario analysis.”Source: pharmagenesis.com
Also offers: Publication Planning & Management, Medical Communications Writing, +3 more
Service Provider · +3 more types
Products: TrinityEDGE, InsightsEDGE +6 more
“Support your payer value story and medical value narrative with robust real-world data, dossiers, and HECON modeling.”Source: trinitylifesciences.com
Also offers: Market Research & Primary Insights, Product Launch Strategy & Readiness, +2 more
Consulting / Advisory Firm · +2 more types
“Developing core market access deliverables: value proposition, value dossier, and cost-effectiveness and budgetary impact models”Source: voisinconsulting.com
Also offers: Regulatory Development Strategy & Agency Interactions, Market Access Strategy & Launch Planning, +3 more
What this covers: Economic models and analyses used to demonstrate value, cost-effectiveness, and payer budget impact.
| Vendor | Delivery model | Also offers | In their words |
|---|---|---|---|
| Axtria | Software / Technology Platform | Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Flexible RWD simulations and real-world analytics enabled label expansion, clinical guideline updates, and economic models for payer engagement, strengthening…”axtria.com · reviewed Oct 26, 2026 |
| Costello Medical | Agency | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “From sophisticated global economic models to HTA-ready cost-effectiveness analyses, local budget impact models and user-friendly market access tools, our…”costellomedical.com · reviewed Oct 21, 2026 |
| IQVIA | CRO / Research Services Provider | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Partner with IQVIA to access health economic modeling solutions to support market-specific reimbursement, market access and high-impact scientific publications.”iqvia.com · reviewed Oct 20, 2026 |
| Klick Health | Agency | — | “We use customized healthcare economic modeling tools that demonstrate value by aligning clinical benefit with relevant cost impact. Our tools allow formulary…”klick.com · reviewed Oct 25, 2026 |
| Komodo Health | Software / Technology Platform | Outcomes Research & Burden of Illness, RWE for Access & HEOR | “Run cost-effectiveness studies of varying interventions, support post-market surveillance, and boost HEOR studies.”komodohealth.com · reviewed Oct 21, 2026 |
| Lumanity | Consulting / Advisory Firm | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “We provide health economic modeling at every stage of the drug development process.”lumanity.com · reviewed Oct 21, 2026 |
| OPEN Health | Consulting / Advisory Firm | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Builds economic models and comparative analyses to demonstrate clinical and economic value.”openhealthgroup.com · reviewed Oct 17, 2026 |
| Oxford PharmaGenesis | Agency | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Our technical experts and trusted partners support economic model development and adaptation, from identifying inputs, developing, adapting, stress-testing and…”pharmagenesis.com · reviewed Oct 20, 2026 |
| Precision AQ | Agency | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “We develop credible evidence-based health economic models to quantify the value and population health impact of your healthcare innovation: cost-effectiveness…”precisionaq.com · reviewed Oct 25, 2026 |
| ProductLife Group | Service Provider | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “We build cost-utility analyses, cost-effectiveness analyses, and cost-benefit models tailored to HTA body requirements and payer decision frameworks across…”plglifesciences.com · reviewed Oct 26, 2026 |
| Trinity Life Sciences | Service Provider | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Support your payer value story and medical value narrative with robust real-world data, dossiers, and HECON modeling.”trinitylifesciences.com · reviewed Oct 21, 2026 |
| Voisin Consulting Life Sciences | Consulting / Advisory Firm | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Developing core market access deliverables: value proposition, value dossier, and cost-effectiveness and budgetary impact models”voisinconsulting.com · reviewed Oct 20, 2026 |